Newsroom
Top Results
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024
<div class=”ndq-section”> <div id=”ndq-content” class=”row ndq-9211″> <div class=”column large-12″> <div class=”region region-content”> <div data-drupal-messages-fallback=”” class=”hidden”></div> <div id=”block-nir-pid4158-content” class=”block–system-main-block block–system-main-block–9211 block–content–system-main-block block–content–system-main-block–9211 block–d3e5cab3-701e-469f-8150-a0c2ef34d4c7 block–d3e5cab3-701e-469f-8150-a0c2ef34d4c7–9211 block block-system block-system-main-block”> <article class=”node node–nir-news–full node–type-nir-news node–view-mode-full node–promoted”> <div class=”file-link pdf-file-link”> <span class=”file file–mime-application-pdf file–application-pdf”><a href=”/wp-content/uploads/sites/4/2024/10/Sight-Sciences-to-Report-Third-Quarter-Financial-Results-on-November-7-2024.pdf” type=”application/pdf” target=”_blank” rel=”noopener”>PDF Version</a></span> </div> <div class=”node__content”> <div class=”box__wrap”> </div> <p align=”justify”>MENLO PARK, Calif., […]
Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance
PDF Version MENLO PARK, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial results for the second quarter ended June 30, 2024, and narrowed financial guidance […]
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
PDF Version MENLO PARK, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced that it will present at the upcoming Morgan Stanley Global Healthcare Conference, in New […]
Sight Sciences to Report Second Quarter Financial Results on August 1, 2024
MENLO PARK, Calif., July 18, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced it will report financial results for the second quarter ended June 30, 2024, after the market […]
Sight Sciences Announces the Release of its First Sustainability Report
PDF Version The Sustainability Report provides data for 2021 through 2023 on the Company’s environmental, social, and governance initiatives MENLO PARK, Calif., June 10, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of […]
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
PDF Version The analysis published in Clinical Ophthalmology suggests that OMNI was as effective at lowering IOP and reducing medication usage in advanced glaucoma as it was in mild and moderate glaucoma. MENLO PARK, Calif., May 28, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company […]
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
PDF Version MENLO PARK, Calif., May 07, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced it will present at the upcoming Bank of America Healthcare Conference, in Las Vegas, […]
Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
PDF Version MENLO PARK, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial results for the first quarter ended March 31, 2024, and reaffirmed financial guidance […]
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
PDF Version MENLO PARK, Calif., April 29, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced that it received a positive jury trial verdict of $34 million associated with the patent infringement case […]